Maheshi Ramasamy
Senior Clinical Researcher
Dr Maheshi Ramasamy obtained her medical degree at Christ's College, University of Cambridge. She trained in Infectious Diseases and General Internal Medicine and obtained a DPhil at Wadham College, University of Oxford investigating B cell responses to conjugate and polysaccharide meningococcal vaccines.
As a Principal Investigator at the Oxford Vaccine Group, she leads on adult clinical vaccine trials and her research interest is in adaptive immune responses to vaccines.
She is a Consultant Physician at the Oxford University Hospitals NHS Foundation Trust and is an Honorary Senior Clinical Lecturer at the University of Oxford.
Recent publications
-
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Journal article
Stuart ASV. et al, (2021), Lancet
-
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
Journal article
Clemens SAC. et al, (2021), Nature Communications, 12
-
Synthesis and Characterization of the Ethylene-Carbonate-Linked L-Valine Derivatives of 4,4-Dimethylcurcumin with Potential Anticancer Activities.
Journal article
Lee D-Y. et al, (2021), Molecules, 26
-
Incidence of non-typhoidal Salmonella invasive disease: A systematic review and meta-analysis
Journal article
Marchello CS. et al, (2021), Journal of Infection, 83, 523 - 532